Drug Profile
Anti-RSV antibody - Intracell
Alternative Names: Human anti-RSV antibody - IntracellLatest Information Update: 22 Apr 2003
Price :
$50
*
At a glance
- Originator Intracel Corporation
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Respiratory syncytial virus infections
Most Recent Events
- 17 Jul 2000 Preclinical development for Respiratory syncytial virus infections in USA (Unknown route)